CNS Pharmaceuticals Announces Attendance at the 24th Annual Meeting of the Society of Neuro-Oncology Nov 20, 2019 8:00am EST
CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals Nov 19, 2019 8:00am EST
CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock Nov 13, 2019 4:15pm EST
